K203144 is an FDA 510(k) clearance for the MicroPen EVO. This device is classified as a Powered Microneedle Device (Class II - Special Controls, product code QAI).
Submitted by Eclipse Medcorp, LLC (The Colony, US). The FDA issued a Cleared decision on May 25, 2021, 216 days after receiving the submission on October 21, 2020.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4430. A Powered Microneedle Device Is A Device Using One Or More Needles To Mechanically Puncture And Injure Skin Tissue For Aesthetic Use..